[ 1 ] Zhang J S, Ding J, Tang QM, Li M, Zhao M, Lu L J, Chen L J, Yuan S T. Synthesis and antitumor activity of novel diterpenequinone salvicineand the analogs. Bioorg. Med. Chem. Lett., 1999,9 :2731 —2736. [ 2 ] Qing C, Zhang J S, Ding J. In vitro cytotoxicity of salvicine, a novel diterpenoid quinone. Acta Pharmacol Sin., 1999,20 :297 —302. [ 3 ] Meng L H, He X H, Zhang J S, Ding J. DNA topoisomerase Ⅱ as primary cellular target for salvicine in Saccharomyces cerevisiae. ActaPharmacol Sin., 2001,21 :741 —746. [ 4 ] Meng, L H, Zhang J S, Ding J. Salvicine, a novel DNA topoisomerase Ⅱinhibitor, exerting its effect by trapping the enzyme2DNA cleavagecomplex. Biochem. Pharmacol, 2001,62 :733 —741. [ 5 ] Miao Z H, Tang T, Zhang Y X, Zhang J S, Ding J. Cytotoxicity, apoptosis induction and downregulation of mdr21 expression by the anti2topoisomerase II agent, salvicine, in multidrug2resistant cells. Int. J. Cancer, 2003,106 :108 —115. [ 6 ] Miao Z H, Ding J. Transcription factor c2Jun activation represses mdr21 gene expression. Cancer Res., 2003, 63 : 4527 —4532. [ 7 ] Miao Z H, Tong L J, Zhang J S, Han J X, Ding J. Characterization of salvicine2resistant lung adenocarcinoma A549PSAL cell line. Int. J.Cancer,2004,110 :627 —632 |